Financials
- Market Capitalization 678.23 M
- Employee 113
- Founded 2009
- CEO N/A
- Website www.aurabiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00226DGM5
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.1
Rapporto prezzo/fatturato
49.59
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2628 | DSGN Design Therapeutics, Inc. - Common Stock | 10.92 USD | -6.27% | -12.08% | -25.76% | +61.78% | 683.39 M USD | ||
| 2636 | MDXG MiMedx Group, Inc - Common Stock | 4.82 USD | +3.21% | +5.93% | +6.17% | -26.75% | 702.57 M USD | ||
| 2663 | PHAR Pharming Group N.V. - ADS, each representing 10 | 9.61 USD | -1.84% | -2.54% | -10.85% | -34.04% | 674.31 M USD | ||
| 2664 | ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.26 USD | -1.14% | +9.32% | -6.40% | +5.83% | 668.66 M USD |